Co-reporter:Qing-Qing YAO, Zhen-Hua LIU, Ming-Cheng XU, Hai-Hong HU, ... Su ZENG
Chinese Journal of Natural Medicines 2017 Volume 15, Issue 5(Volume 15, Issue 5) pp:
Publication Date(Web):1 May 2017
DOI:10.1016/S1875-5364(17)30058-4
Ginkgolic acids (GAs), primarily found in the leaves, nuts, and testa of ginkgo biloba, have been identified with suspected allergenic, genotoxic and cytotoxic properties. However, little information is available about GAs toxicity in kidneys and the underlying mechanism has not been thoroughly elucidated so far. Instead of GAs extract, the renal cytotoxicity of GA (15 : 1), which was isolated from the testa of Ginkgo biloba, was assessed in vitro by using MDCK cells. The action of GA (15 : 1) on cell viability was evaluated by the MTT and neutral red uptake assays. Compared with the control, the cytotoxicity of GA (15 : 1) on MDCK cells displayed a time- and dose-dependent manner, suggesting the cells mitochondria and lysosomes were damaged. It was confirmed that GA (15 : 1) resulted in the loss of cells mitochondrial trans-membrane potential (ΔΨm). In propidium iodide (PI) staining analysis, GA (15 : 1) induced cell cycle arrest at the G0/G1 and G2/M phases, influencing on the DNA synthesis and cell mitosis. Characteristics of necrotic cell death were observed in MDCK cells at the experimental conditions, as a result of DNA agarose gel electrophoresis and morphological observation of MDCK cells. In conclusion, these findings might provide useful information for a better understanding of the GA (15 : 1) induced renal toxicity.
Co-reporter:Hua Wang;Xiaoli Zheng;Qianying Zhu;Qinqin Yu;Yanqing Liu;Lingmin Yuan;Huidi Jiang;Fuqing Tan;Lushan Yu
Science Translational Medicine 2017 Volume 9(Issue 391) pp:
Publication Date(Web):24 May 2017
DOI:10.1126/scitranslmed.aam6298
OCT2 plays a key role in synergy between decitabine and oxaliplatin in renal cell carcinoma cell lines.
Co-reporter:Lu Wang;Yunfeng Chai;Wenquan Zhu;Yuanjiang Pan;Cuirong Sun
Analyst (1876-Present) 2017 vol. 142(Issue 5) pp:745-751
Publication Date(Web):2017/02/27
DOI:10.1039/C6AN02666D
Mutual chiral recognition of four stereoisomers of tadalafil and three pairs of enantiomers of proton pump inhibitors (PPIs) including pantoprazole, lansoprazole, and omeprazole, as well as quantitative analysis of enantiomeric excess is achieved on the basis of the competitive fragmentation of doubly charged trimeric NiII cluster ions. Compared with a singly charged trimeric cluster ion, a doubly charged trimeric cluster ion was proved efficient in the recognition of chiral drugs with one or multiple chiral centers, due to its rich fragmentation ions. Upon collision-induced dissociation (CID), the cluster ion [NiII(PPIs)(tadalafil)2]2+ yielded two diagnostic ions [tadalafil + H]+ and [tadalafil − benzo[d][1,3]dixoloe]+ through electrospray ionization quadrupole time-of-flight mass spectrometry. The abundance ratio of the two fragment ions relied mainly on the configuration of PPIs and tadalafil, and therefore the chiral selectivity (Rchiral) of one enantiomer relative to the others is different. The chiral recognition of all four stereoisomers of tadalafil was achieved by using S configuration PPIs as references, and S-omeprazole showed the best selectivity. The Rchiral values for R,R/S,S, R,S/S,R, R,R/R,S and R,R/S,R-tadalafils were 1.47, 1.17, 2.37, and 2.10, respectively. In a reciprocal process, the Rchiral was 1.36 and 1.31 for R/S-pantoprazole and R/S-lansoprazole, respectively, by using R,R-tadalafil as a reference. Although omeprazole is a racemic drug, it can also be discriminated with S-omeprazole. Calibration curves were constructed with favorable correlation coefficients (r2 > 0.991) by relating the ln(Rchiral) values to the isomeric composition in a mixture. The sensitivity of the methodology allows mixtures to be analyzed for the enantiomeric excess (ee) by recording the ratios of fragment ion abundances in a mass spectrum. The sensitivity of the methodology allowed the determination of enantiomeric impurities of 5% molar composition in individual compounds present in mixtures; the diastereoisomeric impurity of R,R-tadalafil could be quantified even at 1%. We believe that the developed method not only has scientific significance in qualitative and quantitative chiral analyses of tadalafil and PPIs, but also provides great opportunity for enabling the discrimination on a wide range of chiral drugs.
Co-reporter:Yan Lou, Qian Wang, Jinqi Zheng, Haihong Hu, Lin Liu, Dongsheng Hong, and Su Zeng
Chemical Research in Toxicology 2016 Volume 29(Issue 10) pp:1591
Publication Date(Web):September 15, 2016
DOI:10.1021/acs.chemrestox.6b00215
Capecitabine, an oral prodrug of 5-fluorouracil, inhibits DNA synthesis and has received FDA approval for treatment of metastatic colorectal and breast cancers. Hand–foot syndrome (HFS) is a serious dose-limiting toxicity and the most frequently reported side effect of capecitabine. Because of the lack of knowledge about the causative mechanism of HFS, scarce information is available for effective treatment or prevention. Data are based on published literatures and reports available from the HFS development program database. The purpose of this Review is to provide information regarding definition, clinical manifestation, and the possible mechanisms of HFS induced by capecitabine. Ethnic variations in the clinical presentation of HFS warrant further attention. Several physiological and pharmacological mechanisms have been investigated, such as cyclooxygenase (COX) inflammatory-type reaction, accumulation of capecitabine metabolites, and enzymes and transporters involved in the metabolism and absorption. Although current studies describe the possible mechanisms of HFS induced by capecitabine, much remains to be determined. It appears from this scientific evidence that additional study is needed to determine the effect of skin-mediated metabolism in the possible mechanism of HFS induced by capecitabine.
Co-reporter:Zizhao Yang;Lu Wang;Mingcheng Xu;Jingkai Gu;Lushan Yu
Journal of Separation Science 2016 Volume 39( Issue 11) pp:2087-2096
Publication Date(Web):
DOI:10.1002/jssc.201600088
A rapid and sensitive bioassay was established and validated to simultaneously determine gemfibrozil, morphine, morphine-3β-glucuronide, and morphine-6β-glucuronide in mouse cerebrum, epencephalon, and hippocampus based on ultra-high performance liquid chromatography and tandem mass spectrometry. The deuterated internal standard, M6G-d3, was mixed with the prepared samples at 10 ng/mL as the final concentration. The samples were transferred into the C18 solid-phase extraction columns with gradient elution for solid-phase extraction. The mobile phase consisted of methanol and 0.05% formic acid (pH 3.2). Multiple reaction monitoring has been applied to analyze gemfibrozil (m/z 249.0 121.0) in anion mode, and M6G-d3 (m/z 465.1 289.1), morphine (m/z 286.0 200.9), and M3G and M6G (m/z 462.1 286.1) in the positive ion mode. The method has a linear calibration range from 0.05 to 10 ng for gemfibrozil, morphine, and M3G and M6G with correlation coefficients >0.993. The lower limit of quantitation for all four analytes was 0.05 ng/mL, relative standard deviation of intra- and interday precision was less than 10.5%, and the relative error of accuracy was from −8.2 to 8.3% at low, medium, and high concentrations for all the analytes. In conclusion, gemfibrozil can influence the morphine antinociception after coronary heart disease induced chronic angina by the change in one of morphine metabolites', M3G, distribution in mouse brain.
Co-reporter:Qinqin Yu;Yanqing Liu;Hua Wang;Huidi Jiang;Xiaoli Zheng;Lingmin Yuan;Qianying Zhu;Fuqing Tan;Lushan Yu
Science Translational Medicine 2016 Volume 8(Issue 348) pp:348ra97
Publication Date(Web):20 Jul 2016
DOI:10.1126/scitranslmed.aaf3124
The expression of drug transporter OCT2 is suppressed in renal cell carcinoma, and targeting this pathway sensitizes the tumor to oxaliplatin.
Co-reporter:Ye Tian;Shuijie Shen;Yan Jiang;Qi Shen;Jiang Zheng
Archives of Toxicology 2016 Volume 90( Issue 7) pp:1737-1748
Publication Date(Web):2016 July
DOI:10.1007/s00204-015-1584-8
Tetrandrine is a diaryl ether-type bisbenzylisoquinoline alkaloid and has shown multiple pharmacological activities. Our early work demonstrated that tetrandrine produced acute pulmonary toxicity and that tetrandrine was biotransformed to a quinone methide-derived metabolite mediated by CYP3A enzymes. The formation of the reactive intermediate is suggested to be responsible for the pulmonary toxicity induced by tetrandrine. In the present study, a WI-38-based Cyp3a5 transgenic cell line (WI-38/Cyp3a5) was established to investigate the role of CYP3A5 in tetrandrine-induced cytotoxicity. The transgenic cells were found to be more susceptible to the cytotoxicity of tetrandrine than the wild-type cells (WI-38/Vector). WI-38/Cyp3a5 cells showed higher cellular ROS levels, higher LDH activities in culture media, but lower cellular GSH contents than those observed in WI-38/Vector cells after exposure to tetrandrine. And severer apoptosis were observed in WI-38/Cyp3a5 cells after treatment with tetrandrine: WI-38/Cyp3a5 cells had higher proportion of early and late apoptotic cells, higher expression levels of caspase-3, but lower level of Bcl-2 than WI-38/Vector cells. This study provided strong evidence that CYP3A5 participated in tetrandrine-induced cytotoxicity.
Co-reporter:Sheng Cai, Xueke Tian, Lianli Sun, Haihong Hu, Shirui Zheng, Huidi Jiang, Lushan Yu, and Su Zeng
Analytical Chemistry 2015 Volume 87(Issue 20) pp:10542
Publication Date(Web):September 22, 2015
DOI:10.1021/acs.analchem.5b02810
Wide use of platinum-based chemotherapeutic regimens for the treatment for carcinoma calls for a simple and selective detection of platinum compound in biological samples. On the basis of the platinum(II)-base pair coordination, a novel type of aptameric platform for platinum detection has been introduced. This chemiluminescence (CL) aptasensor consists of a designed streptavidin (SA) aptamer sequence in which several base pairs were replaced by G-G mismatches. Only in the presence of platinum, coordination occurs between the platinum and G-G base pairs as opposed to the hydrogen-bonded G-C base pairs, which leads to SA aptamer sequence activation, resulting in their binding to SA coated magnetic beads. These Pt-DNA coordination events were monitored by a simple and direct luminol-peroxide CL reaction through horseradish peroxidase (HRP) catalysis with a strong chemiluminescence emission. The validated ranges of quantification were 0.12–240 μM with a limit of detection of 60 nM and selectivity over other metal ions. This assay was also successfully used in urine sample determination. It will be a promising candidate for the detection of platinum in biomedical and environmental samples.
Co-reporter:Changchuan Guo, Yan Jiang, Li Li, Lan Hong, Yuqing Wang, Qian Shen, Yan Lou, Haihong Hu, Hui Zhou, Lushan Yu, Huidi Jiang, Su Zeng
Journal of Pharmaceutical and Biomedical Analysis 2013 Volume 74() pp:92-100
Publication Date(Web):23 February 2013
DOI:10.1016/j.jpba.2012.10.011
The herbal ingredients of isocorydine and protopine were isolated from Dactylicapnos scandens. This study was aimed at developing a liquid chromatography–electrospray ionization-tandem mass spectrometry (LC–ESI-MS/MS) method to quantify isocorydine and protopine in rat plasma and tissues for pharmacokinetic, tissue distribution and excretion studies. Biological samples were processed with ethyl acetate extraction, and corydaline was chosen as the internal standard (IS). The analytes were separated by a C18 column and detected with a triple quadrupole mass spectrometer using positive ion ESI in the multiple reaction monitoring (MRM) mode. The MS/MS ion transitions monitored were m/z 342.0 → 278.9 for isocorydine, 354.1 → 188.0 for protopine and 370.0 → 192.0 for IS, respectively. Excellent linearity was observed over the concentration range between 10 and 3000 ng/mL for isocorydine and 10–300 ng/mL for protopine. The lower limit of quantification (LLOQ) was 10 ng/mL for both isocorydine and protopine. This novel method was rapid, accurate, high sensitive and high selective. It was successfully applied to the pharmacokinetic, tissue distribution and excretion studies of D. scandens. These preclinical data of D. scandens would be useful for the clinical reference.
Co-reporter:Xiao-Li Zheng;Qin-Qin Yu;Yi Wang
Chirality 2013 Volume 25( Issue 6) pp:361-364
Publication Date(Web):
DOI:10.1002/chir.22178
ABSTRACT
The stereoselective uptake of propranolol enantiomers was investigated by using the K562 and K562 adriamycin-resistant cell line (K562/ADR) as a model. An enantioselective RP-HPLC method was applied to determine the accumulation of propranolol (PPL) stereoisomers in K562 and K562/ADR cells. The concentration, time and temperature dependent studies showed that the accumulation of S-(−)-PPL was higher than R-(+)-PPL in K562 cells and uptake of R-(+)-PPL was significantly higher than that of S-(−)-PPL in K562/ADR cells. The results indicate the enantioselective accumulation of propranolol enantiomers in K562 and K562 / ADR cells. Chirality 25:361–364, 2013. © 2013 Wiley Periodicals, Inc.
Co-reporter:Qi Shen;Lu Wang;Hui Zhou;Hui-di Jiang;Lu-shan Yu;Su Zeng
Acta Pharmacologica Sinica 2013 34(8) pp:998-1006
Publication Date(Web):2013-07-15
DOI:10.1038/aps.2013.78
Chiral drugs show distinct biochemical and pharmacological behaviors in the human body. The binding of chiral drugs to plasma proteins usually exhibits stereoselectivity, which has a far-reaching influence on their pharmacological activities and pharmacokinetic profiles. In this review, the stereoselective binding of chiral drugs to human serum albumin (HSA), α1-acid glycoprotein (AGP) and lipoprotein, three most important proteins in human plasma, are detailed. Furthermore, the application of AGP variants and recombinant fragments of HSA for studying enantiomer binding properties is also discussed. Apart from the stereoselectivity of enantiomer-protein binding, enantiomer-enantiomer interactions that may induce allosteric effects are also described. Additionally, the techniques and methods used to determine drug-protein binding parameters are briefly reviewed.
Co-reporter:Lushan Yu, Shengjia Wang, Huidi Jiang, Hui Zhou, Su Zeng
Journal of Chromatography A 2012 Volume 1236() pp:97-104
Publication Date(Web):4 May 2012
DOI:10.1016/j.chroma.2012.03.006
In this study, we developed an LC–MS/MS method based on an isotope discrimination mass spectroscopy solution (IDMSS) technology to simultaneously quantify enantiomers of fluoxetine (FLX) and norfluoxetine (NFLX) in a CYP2C9 incubation mixture. S-FLX and S-NFLX were labeled to form S-FLX-d5 and S-NFLX-d5. The method has several advantages over conventional chiral separation methods, in terms of the analysis period, resolution, and lower limit of quantification. The primary advantage of the method is that the two enantiomers can always be simultaneously determined by mass spectroscopy regardless if they are separated on column or not, owing to which it has high throughput and high sensitivity. The lower limit of quantification (amount on column) is 12.5 and 1.25 pg for FLX and NFLX, respectively. The retention time of FLX, NFLX, and the internal standard is only 1.9 min. The calibration curves were linear over the concentration range of 0.1–100 ng/ml for NFLX and 1–1000 ng/ml for FLX with an accepted reproducible (RSD < 10%) and accurate (CV < 10%). No significant kinetic isotope effect was found in the metabolism of S-FLX-d5 catalyzed by CYP2C9*1 and CYP2C9*2. The half-maximal inhibitory concentration values between R-FLX and S-FLX catalyzed by CYP2C9*1 and CYP2C9*2 were determined in this study. The inhibitory effects of R- to S-FLX were stronger than those of S- to R-FLX in both CYP2C9*1 and CYP2C9*2. The IDMSS technology is useful for stereoselective study of chiral compound in vitro.Highlights► An isotope discrimination MS solution method was developed for chiral separation. ► Separated on column or not is not affect the enantiomers determination. ► The method has high throughput and high sensitivity. ► No significant kinetic isotope effect was found to the S-fluoxetine-d5 metabolism.
Co-reporter:Xiaodan Wang, Hui Zhou, Su Zeng
Journal of Chromatography B 2012 Volume 911() pp:34-42
Publication Date(Web):12 December 2012
DOI:10.1016/j.jchromb.2012.09.006
A new metabolite of taxifolin: 3′-O-methyltaxifolin (3′-O-MTAX) in Caco-2 cells and in rat plasma was identified. The chemical structure of 3′-O-MTAX was determined by MS and 1H NMR. A rapid, sensitive and specific UPLC–MS method to determine 3′-O-MTAX in rat plasma was also developed. Following ethyl acetate extraction, 3′-O-MTAX in plasma was separated on a Sunfire™ (2.1 mm × 50 mm, 3.5 μm) column and analyzed in the selected ion recording with a negative electrospray ionization mode using puerarin as the internal standard. The lower limit of quantification (LLOQ) was 2.75 ng/mL. Intra- and inter-day precisions (% RSD) were all within 7.2% and accuracy (% deviation) ranged from −5.0 to 4.7%. The overall recoveries at four concentrations were all >72.0%. This validated method was successfully applied to measure 3′-O-MTAX in rat plasma after oral administration of taxifolin.Highlights► Identified a new metabolite of taxifolin in Caco-2 cells and in rat plasma. ► Prepared the metabolite using Caco-2 cells. ► Evaluated the pharmacokinetic studies of 3′-O-methyltaxifolin in rats.
Co-reporter:Ling-Bo Gao;Jin-Zhao Wang;Tong-Wei Yao
Chirality 2012 Volume 24( Issue 1) pp:86-95
Publication Date(Web):
DOI:10.1002/chir.21031
Abstract
Mandelic acid (MA) is generally used as a biological indicator of occupational exposure to styrene, which is classified as a class of hazardous environmental pollutants. It was found to undergo one-directional chiral inversion (S-MA to R-MA) in Wistar and Sprague-Dawley rats in vivo. This study was aimed to explore the metabolic mechanism of chiral inversion of S-MA in vitro. S-MA was converted to R-MA in rat hepatocytes, whereas MA enantiomers remained unchanged in acidic and neutral phosphate buffers, HepG2 cells, and intestinal flora. In addition, the synthesized S-MA-CoA thioester was rapidly racemized and hydrolyzed to R-MA by rat liver homogenate and S9, cytosolic and mitochondrial fractions. The data suggest that chiral inversion of S-MA may involve the hydrolysis of S-MA-CoA, and its metabolic mechanism could be the same as that of 2-arylpropionic acid (2-APA) drugs. Chirality 24:86–95, 2012. © 2011 Wiley Periodicals, Inc.
Co-reporter:Zheng Xiang;Xian-qin Wang;Xiao-jun Cai
Phytochemical Analysis 2011 Volume 22( Issue 5) pp:411-418
Publication Date(Web):
DOI:10.1002/pca.1296
ABSTRACT
Introduction
Metabonomic analysis is an important molecular phenotyping method for characterising plant ecotypic variations; hence, it may become a powerful tool for quality control and discrimination of traditional Chinese medicine (TCM).
Objective
To discriminate and assess the quality of Curcuma phaeocaulis, C. kwangsiensis and C. wenyujin from different ecotypes. The identification of the compositions of essential oils from the three Curcuma species was included in this study.
Methodology
Metabolomics analysis was carried out on all samples by gas chromatography–mass spectrometry (GC-MS) coupled with multivariate statistical analysis. Characterisation of phytochemicals in essential oils was performed by automated matching to the MS library and comparison of their mass spectra (NIST05 database).
Results
Principal component analysis (PCA) effectively distinguished the samples from different species and ecotypes. Partial least squares discrimination analysis (PLS-DA) was successfully employed in classifying the GC-MS data of authentic, commercial and introduction cultivation samples. Furthermore, the components contributing significantly to the discrimination, namely curzerenone, germacrone, curdione and epicurzerenone, were screened by PCA and PLS-DA loading plots and further can be used as chemical markers for discrimination and quality control among different groups of samples. Copyright © 2011 John Wiley & Sons, Ltd.
Co-reporter:Lan Hong, Wendy Jiang, Wei Zheng, Su Zeng
Journal of Pharmaceutical and Biomedical Analysis 2011 54(5) pp: 1101-1109
Publication Date(Web):
DOI:10.1016/j.jpba.2010.11.031
Co-reporter:Yan Lou, Haihong Hu, Yao Liu, Qinqin Yu, Li Li, Li Ping, Lushan Yu, Huidi Jiang, Su Zeng
Journal of Pharmaceutical and Biomedical Analysis 2011 55(5) pp: 1163-1169
Publication Date(Web):
DOI:10.1016/j.jpba.2011.04.009
Co-reporter:Haina Wang, Jianbo Ji, Su Zeng
Journal of Chromatography B 2011 Volume 879(Issue 24) pp:2430-2436
Publication Date(Web):15 August 2011
DOI:10.1016/j.jchromb.2011.06.043
Zaltoprofen, available commercially as a racemic mixture, is a propionic acid derivative of non-steroidal anti-inflammatory drugs (NSAIDs). Firstly, (+)- and (−)-zaltoprofen glucuronide was biosynthesized and purified. Then a simple and rapid RP-HPLC analysis method for direct determination of (+)- and (−)-zaltoprofen glucuronide in rat hepatic microsomes was developed and validated. The calibration curves of (+)- and (−)-zaltoprofen glucuronide both showed good linearity in the concentration range from 0.15 to 31.13 μM. The lower limit of quantification was 0.15 μM. Finally, this method was used to investigate the enantioselectivity of zaltoprofen glucuronidation in rat hepatic microsomes. The kinetics of zaltoprofen glucuronidation in rat hepatic microsomes for 40 min incubation fit the Michaelis–Menten model. Kinetic analysis indicated that (−)-zaltoprofen had a higher glucuronidation rate in rat liver microsome than that of (+)-zaltoprofen. The catalyzing efficiency (Vmax/Km) ratio of (+)-zaltoprofen to (−)-enantiomer is 0.8 times in rat liver microsomes.
Co-reporter:Lushan Yu;Minrong Qian;Yao Liu;Tongwei Yao
Chirality 2010 Volume 22( Issue 4) pp:456-461
Publication Date(Web):
DOI:10.1002/chir.20765
Abstract
Stereoselective metabolism of propranolol side-chain glucuronidation was studied for two recombinant human uridine diphosphate glucuronosyltransferases (UGTs), UGT1A9 and UGT2B7. The S- and R-propranolol side-chain glucuronides produced in the incubation mixtures were assayed simultaneously by RP-HPLC with fluorescent detector. The excitation and emission wavelengths were set at 310 nm and 339 nm, respectively. UGT1A9 prefers catalyzing S-enantiomer to R-enantiomer and the intrinsic clearance (CLint) ratios of S-enantiomer to R-enantiomer are 3.8 times and 6.5times for racemic propranolol and individual enantiomers, respectively. UGT2B7, however, catalyzes slightly less S-enantiomer than R-enantiomer and the CLint ratio of S-enantiomer to R-enantiomer is 0.8 times. The high concentration of racemic propranolol (>0.57 mmol/l) and individual enantiomers (>0.69 mmol/l) exhibited substrate inhibition of glucuronidation for UGT2B7, but only the S-enantiomer (>0.44 mmol/l) in racemic propranolol exhibited substrate inhibition for UGT1A9. The substrate inhibition constants (Ksi) were all similar (P > 0.05). Drug–drug interactions were also found between S- and R-enantiomer glucuronidation metabolisms by UGT1A9 and UGT2B7. Chirality 2010. © 2009 Wiley-Liss, Inc.
Co-reporter:Ying He;Yao Liu
Chirality 2010 Volume 22( Issue 7) pp:684-692
Publication Date(Web):
DOI:10.1002/chir.20815
Abstract
The aim of this study was to explore potential transport mechanisms of cetirizine enantiomers across Caco-2 cells. Cetirizine displayed polarized transport at concentrations ranging from 4.0 to 80.0 μM, with the permeability in the secretory direction being 1.4- to 4.0-fold higher than that in the absorptive direction. Cetirizine enantiomers were transported distinctively different from each other. In the presence of inhibitors of P-glycoprotein (P-gp) and multidrug resistance-associated protein (MRP), the absorptive transport was enhanced and secretory efflux was diminished. When verapamil, indomethacin, or probenecid were present, the difference in the absorptive permeability of R-cetirizine and S-cetirizine substantially intensified, whereas quinidine could eliminate. R-cetirizine significantly increased the efflux ratio of rhodamine-123 and doxorubicin in a fashion indicative of the upregulation of P-gp and MRP activities. However, S-cetirizine played a role of an inhibitor for P-gp and MRP. Ranitidine modified the absorption of cetirizine enantiomers, suggesting that the potential drug–drug interaction would significantly change the cetirizine pharmacokinetics. In conclusion, the results indicated that there are several efflux transporters including P-gp and MRP participating the absorption and efflux of cetirizine, which showed enantioselectivity in the transmembrane process. In addition, both P-gp and MRP functions could be modulated by cetirizine in chiral discriminative ways. Chirality, 2010. © 2009 Wiley-Liss, Inc.
Co-reporter:Yi Wang;Jiang Cao;Xiaodan Wang
Chirality 2010 Volume 22( Issue 3) pp:361-368
Publication Date(Web):
DOI:10.1002/chir.20753
Abstract
The transport and uptake of individual propranolol (PPL) enantiomers were studied in human intestinal Caco-2 cell monolayers, and a reversed-phase HPLC-UV assay was used for quantitative analysis. S-PPL and R-PPL across Caco-2 cell monolayers was determined in the concentrations range of 10–500 μM in both apical (AP) to basolateral (BL) and BL to AP directions. S-PPL exhibited greater permeability than R-PPL in the AP to BL direction, whereas in the BL to AP direction S-enantiomer transported less than R-enantiomer. Uptake of R-PPL was significantly higher than that of S-PPL either from AP side or from BL side. The statistically significant differences in uptake were observed at the concentrations range from 10 to 50 μM. Furthermore, the apparent Michaelis constant (Km) and maximal velocity (Vmax) also showed significant difference between the two enantiomers. Moreover, the AP to BL transport of PPL enantiomer was markedly decreased by lowering the pH of the apical side but it did not affect the stereoselectivity of PPL across Caco-2 cell monolayers. The transport and uptake of PPL in the BL to AP direction was not influenced by several protein inhibitors. The results suggest that PPL enantiomers showed stereoselective transport and uptake across the Caco-2 cell monolayers. A special transport mechanism capable of directing the PPL enantiomers might be present in the Caco-2 monolayers. Chirality 2010. © 2009 Wiley-Liss, Inc.
Co-reporter:Yanjun Hong;Yihong Tang
Chirality 2009 Volume 21( Issue 7) pp:692-698
Publication Date(Web):
DOI:10.1002/chir.20666
Abstract
The interaction of propafenone (PPF) enantiomers with human plasma, human serum albumin (HSA), α1-acid glycoprotein (AGP), as well as with plasma from rat, rabbit, and cow was investigated using indirect chiral high performance liquid chromatography (HPLC) and ultrafiltration techniques. The stronger binding of the S-PPF found in human plasma was due to AGP. Two classes of binding sites in AGP were identified: one with high-affinity and small binding capacity (K1(S) = 7.65 × 106 M−1, n1(S) = 0.50; K1(R) = 2.81 × 106 M−1, n1(R) = 0.46), which revealed stereoselectivity; the other with low-affinity and high-binding capacity (n2(S)K2(S) = 9.95 × 103 M−1; n2(R)K2(R) = 9.74 × 103 M−1). The binding to HSA was found to be weak and not enantioselective (nKS = 2.08 × 103 M−1, nKR = 2.05 × 103 M−1). The interaction between enantiomers observed in human plasma was confirmed as a competitive type interacting at the high-affinity site in AGP. The binding mode of both enantiomers with AGP was mainly hydrophobic bond. PPF enantiomers had higher-binding affinity for the F-S variant of human AGP. Drug-drug binding interaction studies showed that verapamil, diazepam, nifedipine, furosemide, nitrendipine, and nimodipine did not affect the binding of PPF enantiomers except quinidine and aprindine at the therapeutic concentration. Comparative studies indicated considerable species-dependent binding stereoselectivity between plasma of the four species investigated. Chirality, 2009. © 2008 Wiley-Liss, Inc.
Co-reporter:Xiaodan Wang, Hongjun Xia, Feng Xing, Guifeng Deng, Qi Shen, Su Zeng
Journal of Chromatography B 2009 Volume 877(18–19) pp:1778-1786
Publication Date(Web):15 June 2009
DOI:10.1016/j.jchromb.2009.04.037
A sensitive ultra performance liquid chromatography–mass spectrometry method has been developed and validated for the quantification of taxifolin in rat plasma. Following liquid/liquid extraction by ethyl acetate, the analytes were separated on a Sunfire™ (2.1 mm × 50 mm, 3.5 μm) column and analyzed in the selected ion recording with a negative electrospray ionization mode. The method was linear over the concentration range of 6–6750 ng/mL. Intra- and inter-day precisions were all within 8% and accuracy ranged from 92.9% to 105.1%. The lower limit of quantification was 6 ng/mL. The present method was successfully applied to the estimation of the pharmacokinetic parameters of taxifolin following intravenous and oral administration to rats. The absolute bioavailability of taxifolin was 0.17% in rat.
Co-reporter:Chang Xin Zhou, Xiang Yi Zhang, Xiao Wu Dong, Qiao Feng Tao, Hui Dou, Rong Ping Zhang, Ke Xin Huang, Xiao Kun Li, Chang Xiang Chen, Su Zeng, Yu Zhao
Chinese Chemical Letters 2007 Volume 18(Issue 10) pp:1243-1246
Publication Date(Web):October 2007
DOI:10.1016/j.cclet.2007.08.001
Three new diarylheptanoids, i.e., sodium(5S,2E)-1,7-bis(4-hydroxyphenyl)-1-hydroxy-2-hepten-5-sulfonate (1), sodium(5R,2E)-1,7-bis(4-hydroxyphenyl)-1-hydroxy-2-hepten-5-sulfonate (2) and 3,5-diacetoxy-1-(3-methoxy-4,5-dihydroxyphenyl)-7-(4-hydroxy-3-methoxyphenyl)heptane (3) were isolated from the rhizomes of Zingiber officinale. The structures of the new compounds were elucidated on the basis of spectroscopic methods. The antioxidant activities of 3 were assayed by in vitro models involving DPPH free radicals and superoxide anion radicals.
Co-reporter:Ying He;Shuijie Shen
Chirality 2007 Volume 19(Issue 6) pp:485-490
Publication Date(Web):29 MAR 2007
DOI:10.1002/chir.20400
MDR1-encoded P-glycoprotein (P-gp) is a drug efflux transporter mainly expressed in liver, kidney, intestine, brain (at the level of the blood-brain barrier), and placenta. It thus plays important roles in drug absorption, distribution, and excretion. Cetirizine is a second-generation nonsedating antihistamine used to treat allergic disease of respiratory system, skin and eyes. To evaluate P-gp expression and function in Caco-2 cells pretreated with cetirizine enantiomers, we assessed the sensitivity of Caco-2 cells to paclitaxel using the MTT assay and the polarized transport of rhodamine-123 and doxorubicin across Caco-2 monolayers. RT-PCR and flow cytometry were used to assay MDR1 mRNA and P-gp protein respectively. The sensitivity of Caco-2 cells to paclitaxel decreased significantly after cells were pretreated with 100 μM R-cetirizine but increased upon treatment with S-cetirizine. The efflux of rhodamine-123 and doxorubicin was enhanced significantly after Caco-2 monolayers were pretreated with 100 μM R-cetirizine but was reduced by S-cetirizine. The MDR1 mRNA and P-gp levels in Caco-2 cells were increased by 100 μM R-cetirizine and decreased by 100 μM S-cetirizine. These results suggest that R-cetirizine up-regulates MDR1 expression while S-cetirizine down-regulates MDR1 expression. Chirality, 2007. © 2007 Wiley-Liss, Inc.
Co-reporter:Sheng-Hao Wang;Li-Na Yin;Ze-Hua Liang;Si-Jie Lu
Chirality 2007 Volume 19(Issue 10) pp:769-774
Publication Date(Web):8 AUG 2007
DOI:10.1002/chir.20453
The stereoselectivity of release of ketoprofen (KET) enantiomers from a biodegradable injectable implant containing racemic KET (rac-KET) was investigated in vivo. A pre-column chiral derivatization RP-HPLC method was employed to assay diastereoisomeric derivatives of R- and S-KET. The rac-KET injectable implant, once injected subcutaneously in rats, produced long-lasting plasma levels of S-KET, which were always greater than those of R-KET. The difference in enantiomer concentration was to be related to stereoselective release, due to stereoselective interaction between D,L-PLG in the implant and KET enantiomers, as well as the chiral inversion of KET in vivo. The rac-KET injectable implant provided the sustained release of S-KET with effective plasma levels maintained for about 8 wk after a single injection. Chirality 2007. © 2007 Wiley-Liss, Inc.
Co-reporter:Lin-ya You;Chun-na Yu;Sheng-gu Xie
Journal of Zhejiang University-SCIENCE B 2007 Volume 8( Issue 10) pp:756-764
Publication Date(Web):2007 September
DOI:10.1631/jzus.2007.B0756
To study the stereoselective glucuronidation of carvedilol (CARV) by three Chinese liver microsomes.The metabolites of CARV were identified by a hydrolysis reaction with β-glucuronidase and HPLC-MS/MS. The enzyme kinetics for CARV enantiomers glucuronidation was determined by a reversed phase-high pressure liquid chromatography (RP-HPLC) assay using (S)-propafenone as internal standard after precolumn derivatization with 2,3,4,6-tetra-O-acetyl-β-D-glucopyranosylisothiocyanate.Two CARV glucuronides were found in three Chinese liver microsomes incubated with CARV. The non-linear regression analysis showed that the values of Km and Vmax for (S)-CARV and (R)-CARV enantiomers were (118±44) μmol/L, (2500±833) pmol/(min·mg protein) and (24±7) μmol/L, (953±399) pmol/(min·mg protein), respectively.These results suggested that there was a significant (P<0.05) stereoselective glucuronidation of CARV enantiomers in three Chinese liver microsomes, which might partly explain the enantioselective pharmacokinetics of CARV.
Co-reporter:Jincui Ye, Guosheng Chen, Su Zeng
Journal of Chromatography B 2006 Volume 843(Issue 2) pp:289-294
Publication Date(Web):7 November 2006
DOI:10.1016/j.jchromb.2006.06.017
The chiral separation of norgestrel enantiomers using reversed-phase high-performance liquid chromatography (RP-HPLC) was studied with hydroxypropyl-beta-cyclodextrin (HP-beta-CD) as chiral mobile phase additive. The effect of mobile phase composition, concentration of HP-beta-CD and column temperature on enantioselective separation were investigated. The quantification properties of the developed RP-HPLC method were examined. A baseline separation of norgestrel enantiomers was achieved on a Agilent ZORBAX Eclipse XDB-C8 column (150 mm × 4.6 mm i.d., 5 μm). The mobile phase was a mixture of acetonitrile and phosphate buffer (pH 5.0, 20 mM) containing 25 mM HP-beta-CD (30:70, v/v) with a flow rate of 1.0 ml/min. The UV detector was set at 240 nm. Calibration curves were linear (n = 8) in the range of 0.2–25 μg/ml, the limit of detection and quantitation were 0.10 and 0.20 μg/ml, respectively, for racemic norgestrel. The values of RSD of repeatability and intermediate precision for spiked sample were less than 4.8%. The method was successfully applied to the enantioselective determination of this drug in stereoselective skin permeation study.
Co-reporter:Yi Wang, Jiang Cao, Jian-Hua Weng, Su Zeng
Journal of Pharmaceutical and Biomedical Analysis 2005 Volume 39(1–2) pp:328-333
Publication Date(Web):1 September 2005
DOI:10.1016/j.jpba.2005.03.016
Quercetin, kaempferol and isorhamnetin are the most important constituents in ginkgo flavonoids. A simple, rapid and sensitive high-performance liquid chromatography method was developed to simultaneously determine quercetin, kaempferol and isorhamnetin absorped by human breast cancer cells. Cells were treated with ginkgo flavonols and then lysed with Triton-X 100. The flavonols in the samples were measured by RP-HPLC with a C18 column after a simple extraction with a mixture of ether and acetone. The mobile phase contained phosphate buffer (pH 2.0; 10 mM) tetrahydrofuran, methanol and isopropanol (65:15:10:20, v/v/v/v). The ultraviolet detector was operated at 380 nm. The calibration curve was linear from 0.1 to 1.0 μM (r > 0.999) for each flavonol. The mean extraction efficiency was about 70%. The recovery of the assay was between 98.9 and 100.6%. The limit of detection was 0.01 μM for quercetin and kaempferol and 0.05 μM for isorhamnetin. The limit of quantitation was 0.1 μM (R.S.D. < 10%) for each flavonol. The intra- and inter-day coefficients of variation were less than 10% (R.S.D.). The validated method was applied to quantify quercetin, kaempferol and isorhamnetin in human breast cancer Bcap37 and Bcap37/MDR1 cells.
Co-reporter:Lushan Yu, Zhangting Wang, Minmin Huang, Yingying Li, Kui Zeng, Jinxiu Lei, Haihong Hu, Baian Chen, Jing Lu, Wen Xie, Su Zeng
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (September 2016) Volume 1859(Issue 9) pp:
Publication Date(Web):September 2016
DOI:10.1016/j.bbagrm.2015.10.001
•Rutaecarpine and evodiamine can active the human and rat CAR.•Rutaecarpine and evodiamine exhibit anti-lipogenic and anti-gluconeogenic effects.•CAR-mediated inhibition of FoxO1 and HNF4α onto gluconeogenic gene promoters•Rutaecarpine treatment improves glucose tolerance in a CAR-dependent manner in mice.The constitutive androstane receptor (CAR) is a key sensor in xenobiotic detoxification and endobiotic metabolism. Increasing evidence suggests that CAR also plays a role in energy metabolism by suppressing the hepatic gluconeogenesis and lipogenesis. In this study, we investigated the effects of two evodia alkaloids, rutaecarpine (Rut) and evodiamine (Evo), on gluconeogenesis and lipogenesis through their activation of the human CAR (hCAR). We found that both Rut and Evo exhibited anti-lipogenic and anti-gluconeogenic effects in the hyperlipidemic HepG2 cells. Both compounds can potently activate hCAR, and treatment of cells with hCAR antagonists reversed the anti-lipogenic and anti-gluconeogenic effects of Rut and Evo. The anti-gluconeogenic effect of Rut and Evo was due to the CAR-mediated inhibition of the recruitment of forkhead box O1 (FoxO1) and hepatocyte nuclear factor 4α (HNF4α) onto the phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase) gene promoters. In vivo, we showed that treatment of mice with Rut improved glucose tolerance in a CAR-dependent manner. Our results suggest that the evodia alkaloids Rut and Evo may have a therapeutic potential for the treatment of hyperglycemia and type 2 diabetes. This article is part of a Special Issue entitled: Xenobiotic nuclear receptors: New Tricks for An Old Dog, edited by Dr. Wen Xie.
Co-reporter:Siyun Xu, Yongsheng Xiao, Li Li, Lushan Yu, Huidi Jiang, Aiming Yu, Su Zeng
Acta Pharmaceutica Sinica B (October 2014) Volume 4(Issue 5) pp:
Publication Date(Web):1 October 2014
DOI:10.1016/j.apsb.2014.08.003
RNA interference (RNAi) is useful for selective gene silencing. Cytochrome P450 3A4 (CYP3A4), which metabolizes approximately 50% of drugs in clinical use, plays an important role in drug metabolism. In this study, we aimed to develop a short hairpin RNA (shRNA) to modulate CYP3A4 expression. Three new shRNAs (S1, S2 and S3) were designed to target the coding sequence (CDS) of CYP3A4, cloned into a shRNA expression vector, and tested in different cells. The mixture of three shRNAs produced optimal reduction (55%) in CYP3A4 CDS-luciferase activity in both CHL and HEK293 cells. Endogenous CYP3A4 expression in HepG2 cells was decreased about 50% at both mRNA and protein level after transfection of the mixture of three shRNAs. In contrast, CYP3A5 gene expression was not altered by the shRNAs, supporting the selectivity of CYP3A4 shRNAs. In addition, HepG2 cells transfected with CYP3A4 shRNAs were less sensitive to Ginkgolic acids, whose toxic metabolites are produced by CYP3A4. These results demonstrate that vector-based shRNAs could modulate CYP3A4 expression in cells through their actions on CYP3A4 CDS, and CYP3A4 shRNAs may be utilized to define the role of CYP3A4 in drug metabolism and toxicity.A mixture of three new vector-based shRNAs targeting CYP3A4 coding sequence can selectively inhibit its expression in CHL, HEK293 and HepG2 cells. In addition, HepG2 cells transfected with these shRNAs were less sensitive to Ginkgolic acids, whose toxic metabolites are produced by CYP3A4. Download full-size image
Co-reporter:Yi-Hong Tang, Jun-Yan Wang, Hai-Hong Hu, Tong-Wei Yao, Su Zeng
Journal of Pharmaceutical Analysis (June 2012) Volume 2(Issue 3) pp:220-225
Publication Date(Web):1 June 2012
DOI:10.1016/j.jpha.2012.01.007
The stereoselective hydrolysis of esmolol in whole blood and in its separated components from rat, rabbit and human was investigated. Blood esterase activities were variable in different species in the order of rat>rabbit>human. Rat plasma showed the high esterase activity and had no stereoselectivity to enantiomers. Rabbit red blood cell (RBC) membrane, RBC cytosol and plasma all hydrolyzed esmolol but with different esterase activity, whereas the hydrolysis in RBC membrane and cytosol showed significant stereoselectivity towards R-(+)-esmolol. Esterase in RBC cytosol from human blood mainly contributed to the esmolol hydrolysis, which was demonstrated with no stereoselctivity. Esterase in human plasma showed a low activity, but a remarkable stereoselectivity with R-(+)-esmolol. In addition, the protein concentration affected the hydrolysis behavior of esmolol in RBC suspension. Protein binding of esmolol enantiomers in human plasma, human serum albumin (HSA) and α1-acid glycoprotein (AGP) revealed that there was a significant difference in bound fractions between two enantiomers, especially for AGP. Our results indicated that the stereoselective protein binding might play a role in the different hydrolysis rates of esmolol enantiomers in human plasma.
Co-reporter:Zhuowei Shen, Chuang Lv, Su Zeng
Journal of Pharmaceutical Analysis (February 2016) Volume 6(Issue 1) pp:1-10
Publication Date(Web):1 February 2016
DOI:10.1016/j.jpha.2015.12.004
Stereoselectivity in drug metabolism can not only influence the pharmacological activities, tolerability, safety, and bioavailability of drugs directly, but also cause different kinds of drug–drug interactions. Thus, assessing stereoselectivity in drug metabolism is of great significance for pharmaceutical research and development (R&D) and rational use in clinic. Although there are various methods available for assessing stereoselectivity in drug metabolism, many of them have shortcomings. The indirect method of chromatographic methods can only be applicable to specific samples with functional groups to be derivatized or form complex with a chiral selector, while the direct method achieved by chiral stationary phases (CSPs) is expensive. As a detector of chromatographic methods, mass spectrometry (MS) is highly sensitive and specific, whereas the matrix interference is still a challenge to overcome. In addition, the use of nuclear magnetic resonance (NMR) and immunoassay in chiral analysis are worth noting. This review presents several typical examples of drug stereoselective metabolism and provides a literature-based evaluation on current chiral analytical techniques to show the significance and challenges of stereoselectivity assessing methods in drug metabolism.
Co-reporter:Chang-Chuan Guo, Yi-Hong Tang, Hai-Hong Hu, Lu-Shan Yu, ... Su Zeng
Journal of Pharmaceutical Analysis (August 2011) Volume 1(Issue 3) pp:184-190
Publication Date(Web):1 August 2011
DOI:10.1016/j.jpha.2011.06.005
The protein binding of non-steroidal anti-inflammatory drugs flurbiprofen, ketoprofen and etodolac with human serum albumin (HSA) was investigated using indirect chiral high performance liquid chromatography (HPLC) and ultrafiltration techniques. S-(–)-1-(1-naphthyl)-ethylamine (S-NEA) was utilized as chiral derivatization reagent and pre-column derivatization RP-HPLC method was established for the separation and assay of the three pairs of enantiomer. The method had good linear relationship over the investigated concentration range without interference. The average extraction efficiency was higher than 85% in different systems, and the intra-day and inter-day precisions were less than 15%. In serum albumin, the protein binding of etodolac enantiomers showed significant stereoselectivity that the affinity of S-enantiomer was stronger than R-enantiomer, and the stereoselectivity ratio reached 6.06; Flurbiprofen had only weak stereoselectivity in HSA, and ketoprofen had no stereoselectivity at all. Scatchard curves showed that all the three chiral drugs had two types of binding sites in HSA.
Co-reporter:Ye Tian, Ying He, Haihong Hu, Lu Wang, Su Zeng
Acta Pharmaceutica Sinica B (April 2012) Volume 2(Issue 2) pp:168-173
Publication Date(Web):April 2012
DOI:10.1016/j.apsb.2012.02.005
Co-reporter:Z.H. Liu, S. Zeng
Toxicology Letters (22 June 2009) Volume 187(Issue 3) pp:131-136
Publication Date(Web):22 June 2009
DOI:10.1016/j.toxlet.2009.02.012
Ginkgolic acids and related alkylphenols (e.g. cardanols and cardols) have been recognized as hazardous compounds with suspected cytotoxic, allergenic, mutagenic and carcinogenic properties. To determine whether the phase I metabolism could contribute to their cytotoxicity, we investigated the cytotoxicity of one model compound, ginkgolic acid (15:1), using in vitro bioassay systems. In the first step, cytochrome P450 enzymes involved in ginkgolic acid metabolism were investigated in rat liver microsomes; then, two in vitro cell-based assay systems, primary rat hepatocytes and HepG2 cells, were used to study and the measurement of MTT reduction was used to assess cell viability. Results indicated that the cytotoxicity of ginkgolic acid in primary rat hepatocytes was lower than in HepG2 cells. Ginkgolic acid was demonstrated less cytotoxicity in four-day-cultured primary rat hepatocytes than in 20-h cultured ones. Co-incubation with selective CYP inhibitors, α-naphthoflavone and ketoconazole, could decrease the cytotoxicity of ginkgolic acid in primary rat hepatocytes. In agreement, pretreatment with selective CYP inducers, β-naphthoflavone and rifampin, could increase the cytotoxicity of ginkgolic acid in HepG2 cells. These findings suggest that HepG2 cells were more sensitive to the cytotoxicity of ginkgolic acid than primary rat hepatocytes, and CYP1A and CYP3A could metabolize ginkgolic acid to more toxic compounds.
Co-reporter:Qiuxia Chen, Yicong Bian, Su Zeng
Drug Metabolism and Pharmacokinetics (2014) Volume 29(Issue 2) pp:223-226
Publication Date(Web):1 January 2014
DOI:10.2133/dmpk.DMPK-13-SH-068
Caco-2 is a widely used cell model in drug absorption and P-glycoprotein (P-gp, MDR1) substrate identification. Long-term vinblastine treatment of Caco-2 cells could increase the expression of P-gp; thus, the vinblastine resistant Caco-2 (Caco-2 vbl) cells can be used as a rapid and sensitive alternative model in identifying P-gp substrates. The mechanism of P-gp induction in this model is not clear; this study was therefore intended to clarify the possible factors involved in P-gp up-regulation in Caco-2 vbl cells. Since vinblastine is the inducer of both activator protein-1 (AP-1) and nuclear factor kappa B (NF-κB), we investigated the role of AP-1 and NF-κB in the regulation of MDR1 gene expression. Our results indicated that the AP-1 and NF-κB luciferase activity was higher in Caco-2 vbl cells than that in Caco-2 cells according to reporter gene assay. The mRNA expression of AP-1 subunit c-Jun and NF-κB was increased in Caco-2 vbl cells. The c-Jun inhibitor SP600125 and NF-κB inhibitor pyrrolidine dithiocarbamate (PDTC) suppressed the expression of MDR1 mRNA in Caco-2 vbl cells. In conclusion, this study provides the evidence that AP-1 and NF-κB are involved in the P-gp induction in Caco-2 vbl cells.
Co-reporter:Liping Ma, Lei Zhao, Haihong Hu, Yahong Qin, Yicong Bian, Huidi Jiang, Hui Zhou, Lushan Yu, Su Zeng
Journal of Ethnopharmacology (14 May 2014) Volume 153(Issue 3) pp:864-871
Publication Date(Web):14 May 2014
DOI:10.1016/j.jep.2014.03.055
Ethnopharmacological relevanceRhubarb is a well-known traditional Chinese medicine and has been used in China for thousands of years. Anthraquinone derivatives including rhein, emodin, aloe-emodin, chrysophanol and physcion are the important components in rhubarb.Materials and methodsHere we studied the interaction of five anthraquinone derivatives with human renal organic anion transporter 1 (hOAT1) and hOAT3 stably expressed in cells, and interaction of rhein or rhubarb extract (RE) with furosemide (FS, substrate of OATs) in rats.ResultsUptake of 6-carboxyl fluorescein via hOAT1 and fluorescein via hOAT3 were markedly inhibited by rhein, emodin and aloe-emodin, and slightly inhibited by chrysophanol and physcion. The estimated IC50 values for rhein, emodin, aloe-emodin and probenecid (typical inhibitor of hOAT1 and hOAT3) were 0.23, 0.61, 2.29 and 18.34 μM for hOAT1, and 0.08, 1.22, 5.37 and 5.83 μM for hOAT3, respectively. Furthermore, the data from the cellular accumulation assay indicated that these five compounds were not substrates of hOAT1 or hOAT3. Pharmacokinetic interaction between rhein and FS in rats showed that area under the curve (AUC0–t) for FS was increased by 65% when coadministrated with rhein. RE was also used to interact with FS in rats and results showed that AUC0–t of FS was increased by 32% and by 52% when coadministrated with single-dose or multiple-dose of RE, respectively.ConclusionsThese findings suggested that five anthraquinones inhibited hOAT1 and hOAT3, but these compounds were not transported by hOAT1 or hOAT3. Furthermore, rhein or RE, might cause drug–drug interaction when coadministrated with substrates of OAT1 or OAT3 in vivo.Download high-res image (156KB)Download full-size image
Co-reporter:Lingmin Yuan, Sainan Qian, Yongsheng Xiao, Hongying Sun, Su Zeng
Biochemical Pharmacology (1 May 2015) Volume 95(Issue 1) pp:58-70
Publication Date(Web):1 May 2015
DOI:10.1016/j.bcp.2015.03.002